1. FRI0059 The efficacy and safety of pegylated recombinant methionyl human soluble tumour necrosis factor receptor type i (peg stnf-ri; p55) in a randomised, placebo-controlled, clinical study of patients with rheumatoid arthritis (ra). (1st June 2001) Authors: Schiff, M; Furst, D; Fleischmann, R; Macri, M; Joh, T; Edwards, CK; Davis, MW Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0096 Effect of anakinra (il-1ra) and soluble tumour necrosis factor receptor i (stnf-ri) on cellular immune function in rats. (1st June 2001) Authors: Atkinson, JE; House, RV; Cranmer, PS; Colucil, AE; Davis, H; Edwards, CK; Miller, DM Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗